Investor Relations

Sensitive, Inexpensive, Disruptive
Diagnostics for all Applications

Interview with Scientific Advisory Board Member
Dr. Sanjiv Chopra

Arrow Dx recently welcomed world-renowned doctor, author, and motivational speaker, Dr. Sanjiv Chopra, to the Arrow Dx Scientific Advisory Board.

In this interview, Dr. Chopra discusses non-alcoholic fatty liver disease (NAFLD) including current detection and treatment for the disease that affects millions worldwide, and how Arrow Dx technology aims to help those with NAFLD with early detection.

Interview with Scientific Advisory Board Member
Dr. Sanjiv Chopra

Arrow Dx recently welcomed world-renowned doctor, author, and motivational speaker, Dr. Sanjiv Chopra, to the Arrow Dx Scientific Advisory Board.

In this interview, Dr. Chopra discusses non-alcoholic fatty liver disease (NAFLD) including current detection and treatment for the disease that affects millions worldwide, and how Arrow Dx technology aims to help those with NAFLD with early detection.

Milestones and Achievements

Arrow DX’s proprietary platform technology allows for application to multiple business verticals ranging from the early detection of NAFLD/NASH to Virus detection to Software/AI to Water/Soil testing.
If you are interested in investment or partnership opportunities.